Synthesis and biological activities of novel 17-aminogeldanamycin derivatives
- 3 September 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (20) , 5317-5329
- https://doi.org/10.1016/j.bmc.2004.07.053
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitorsNature, 2003
- Telomerase as a Target for Cancer ImmunotherapyCancer Biology & Therapy, 2003
- Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogsLeukemia, 2002
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- Hsp90The Journal of cell biology, 2001
- Scintillation proximity assay: a versatile high-throughput screening technologyDrug Discovery Today, 1996
- erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationshipsJournal of Medicinal Chemistry, 1995
- Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivativesJournal of Medicinal Chemistry, 1995
- 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationshipsJournal of Medicinal Chemistry, 1993
- Antibiotics with ansa ringsAccounts of Chemical Research, 1972